April 17, 2018 / 6:52 PM / 3 days ago

India's CBI probing Surya Pharmaceuticals in $95 million bank fraud case

NEW DELHI (Reuters) - Indian police have launched an investigation into a Delhi-based pharmaceutical company for allegedly defrauding state-run Punjab & Sind Bank and four other banks of 6.21 billion rupees ($94.57 million), police said.

FILE PHOTO: A man walks past India's Central Bureau of Investigation (CBI) headquarters building in New Delhi, India, March 6, 2018. REUTERS/Adnan Abidi

“Investigation is continuing,” Central Bureau of Investigation (CBI), the federal police, said in a statement on Tuesday. The CBI said the searches were conducted at seven locations and recovered some documents.

The police acted following a complaint from the Punjab & Sind Bank against Surya Pharmaceuticals (SURP.NS), its two promoters and a Dubai-based company, alleging they had defrauded the banks and siphoned off funds through group companies, a police report reviewed by Reuters showed.

Reuters’ attempts to contact officials of Surya Pharmaceuticals and Punjab & Sind Bank officials through phone and email outside office hours remained unanswered.

The finance ministry had earlier asked all banks to step up vigilance following a $2 billion fraud in February at India’s second-biggest state-run lender Punjab National Bank (PNBK.NS).

    Reporting by Nigam Prusty, Writing by Manoj Kumar, Editing by William Maclean

    0 : 0
    • narrow-browser-and-phone
    • medium-browser-and-portrait-tablet
    • landscape-tablet
    • medium-wide-browser
    • wide-browser-and-larger
    • medium-browser-and-landscape-tablet
    • medium-wide-browser-and-larger
    • above-phone
    • portrait-tablet-and-above
    • above-portrait-tablet
    • landscape-tablet-and-above
    • landscape-tablet-and-medium-wide-browser
    • portrait-tablet-and-below
    • landscape-tablet-and-below